Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Molecular crosstalk between cancer and neurodegenerative diseases.

Seo J, Park M.

Cell Mol Life Sci. 2019 Dec 28. doi: 10.1007/s00018-019-03428-3. [Epub ahead of print] Review.

PMID:
31884567
2.

Peptidyl-prolyl isomerase 1 regulates protein phosphatase 2A-mediated topographic phosphorylation of neurofilament proteins.

Rudrabhatla P, Albers W, Pant HC.

J Neurosci. 2009 Nov 25;29(47):14869-80. doi: 10.1523/JNEUROSCI.4469-09.2009.

3.

Phosphorylation-specific peptidyl-prolyl isomerization of neuronal cytoskeletal proteins by Pin1: implications for therapeutics in neurodegeneration.

Rudrabhatla P, Pant HC.

J Alzheimers Dis. 2010;19(2):389-403. doi: 10.3233/JAD-2010-1243. Review.

PMID:
20110589
4.

[Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].

Viallard JF, Lacombe F, Belloc F, Pellegrin JL, Reiffers J.

Cancer Radiother. 2001 Apr;5(2):109-29. Review. French.

PMID:
11355576
5.

Pin1 inhibition activates cyclin D and produces neurodegenerative pathology.

Atabay KD, Karabay A.

J Neurochem. 2012 Feb;120(3):430-9. doi: 10.1111/j.1471-4159.2011.07259.x. Epub 2011 May 5.

6.

p53 at the crossroads between cancer and neurodegeneration.

Lanni C, Racchi M, Memo M, Govoni S, Uberti D.

Free Radic Biol Med. 2012 May 1;52(9):1727-33. doi: 10.1016/j.freeradbiomed.2012.02.034. Epub 2012 Mar 3. Review.

PMID:
22387179
7.

Prolyl isomerase Pin1 and neurotrophins: a loop that may determine the fate of cells in cancer and neurodegeneration.

Angelucci F, Hort J.

Ther Adv Med Oncol. 2017 Jan;9(1):59-62. doi: 10.1177/1758834016665776. Epub 2016 Sep 16. Review.

8.

Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.

Pulliam L, Sun B, Mustapic M, Chawla S, Kapogiannis D.

J Neurovirol. 2019 Oct;25(5):702-709. doi: 10.1007/s13365-018-0695-4. Epub 2019 Jan 4.

PMID:
30610738
9.

Regulation of neuronal cytoskeletal protein phosphorylation in neurodegenerative diseases.

Rudrabhatla P.

J Alzheimers Dis. 2014;41(3):671-84. doi: 10.3233/JAD-130794. Review.

PMID:
24748119
10.

Cdk5 at crossroads of protein oligomerization in neurodegenerative diseases: facts and hypotheses.

Wilkaniec A, Czapski GA, Adamczyk A.

J Neurochem. 2016 Jan;136(2):222-33. doi: 10.1111/jnc.13365. Epub 2015 Oct 14. Review.

11.

Autophagy and apoptosis dysfunction in neurodegenerative disorders.

Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, Christoffersson J, Chaabane W, Moghadam AR, Kashani HH, Hashemi M, Owji AA, Łos MJ.

Prog Neurobiol. 2014 Jan;112:24-49. doi: 10.1016/j.pneurobio.2013.10.004. Epub 2013 Nov 6. Review.

12.

An Effective Method to Identify Shared Pathways and Common Factors among Neurodegenerative Diseases.

Li P, Nie Y, Yu J.

PLoS One. 2015 Nov 17;10(11):e0143045. doi: 10.1371/journal.pone.0143045. eCollection 2015.

13.

Emerging roles of extracellular vesicles in neurodegenerative disorders.

You Y, Ikezu T.

Neurobiol Dis. 2019 Oct;130:104512. doi: 10.1016/j.nbd.2019.104512. Epub 2019 Jun 20. Review.

PMID:
31229685
14.

The dual face of connexin-based astroglial Ca(2+) communication: a key player in brain physiology and a prime target in pathology.

De Bock M, Decrock E, Wang N, Bol M, Vinken M, Bultynck G, Leybaert L.

Biochim Biophys Acta. 2014 Oct;1843(10):2211-32. doi: 10.1016/j.bbamcr.2014.04.016. Epub 2014 Apr 21. Review.

15.

The molecular bases of Alzheimer's disease and other neurodegenerative disorders.

Maccioni RB, Muñoz JP, Barbeito L.

Arch Med Res. 2001 Sep-Oct;32(5):367-81. Review.

PMID:
11578751
16.

Efficacy of Natural Compounds in Neurodegenerative Disorders.

Srivastava P, Yadav RS.

Adv Neurobiol. 2016;12:107-23. doi: 10.1007/978-3-319-28383-8_7.

PMID:
27651251
17.

Targeting protein aggregation in neurodegeneration--lessons from polyglutamine disorders.

Weydt P, La Spada AR.

Expert Opin Ther Targets. 2006 Aug;10(4):505-13. Review.

PMID:
16848688
18.

Pin1: a new genetic link between Alzheimer's disease, cancer and aging.

Driver JA, Lu KP.

Curr Aging Sci. 2010 Dec;3(3):158-65. Review.

PMID:
20735350
19.

Cell cycle checkpoint control: The cyclin G1/Mdm2/p53 axis emerges as a strategic target for broad-spectrum cancer gene therapy - A review of molecular mechanisms for oncologists.

Gordon EM, Ravicz JR, Liu S, Chawla SP, Hall FL.

Mol Clin Oncol. 2018 Aug;9(2):115-134. doi: 10.3892/mco.2018.1657. Epub 2018 Jun 14.

20.

Chaperone Mediated Autophagy in the Crosstalk of Neurodegenerative Diseases and Metabolic Disorders.

Alfaro IE, Albornoz A, Molina A, Moreno J, Cordero K, Criollo A, Budini M.

Front Endocrinol (Lausanne). 2019 Jan 31;9:778. doi: 10.3389/fendo.2018.00778. eCollection 2018. Review.

Supplemental Content

Support Center